Actavis
Officials from Actavis recently report on new developments
Published in Lab Business Week, July 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Actavis.
Report 1: Actavis announces that it has withdrawn its interest to acquire the generics division of Merck KGaA.
Actavis has performed extensive due diligence on the division and identified significant potential synergies with Actavis operations. However, the Board of Actavis considers that at the price levels that Actavis understands are being offered for the division by other bidders, the transaction would not produce value for Actavis' shareholders and therefore...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-07-22)
More Articles from Lab Business Week
- Anxiety Disorders
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Paxil - Auriga Laboratories, Inc.
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands - Developmental Biology
Research reports from Trescowthick Laboratories provide new insights into developmental biology - Drug Development
Mylan Announces Final FDA Approval for Terbinafine Hydrochloride Tablets - Drug Development
Roxane Laboratories, Inc. Announces the Launch of Terbinafine Hydrochloride Tablets, 250mg - Image Technology Laboratories, Inc.
Image Technology Laboratories, Inc. Secures Financing - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
